Jonathan Fay
About Jonathan Fay
Jonathan Fay serves as the Medical Director of Medical Affairs in Neurology at Supernus Pharmaceuticals, Inc. He possesses extensive clinical expertise across multiple therapeutic areas, including rheumatology and neurology, and has held various leadership roles in the pharmaceutical industry.
Work at Supernus Pharmaceuticals
Jonathan Fay serves as the Medical Director of Medical Affairs for Neurology at Supernus Pharmaceuticals, Inc. since 2021. In this role, he oversees medical strategies and initiatives related to neurology, contributing to the development and communication of scientific data. His responsibilities include collaborating with cross-functional teams to ensure alignment on medical objectives and supporting the company's product portfolio in the neurology therapeutic area.
Education and Expertise
Jonathan Fay earned his Doctor of Medicine (M.D.) degree from the University of Pittsburgh School of Medicine, where he studied from 2001 to 2005. Prior to this, he obtained a Bachelor of Arts in Comparative History of Ideas, Premedicine, from the University of Washington, graduating Magna Cum Laude in 2001. He possesses clinical expertise in neurology and rheumatology, along with experience in gastrointestinal, dermatology, immuno-oncology, and transplant therapeutic areas.
Background
Before joining Supernus Pharmaceuticals, Jonathan Fay held various positions in the pharmaceutical industry. He worked at AbbVie as Medical Director of Rheumatology from 2018 to 2020. His tenure at Bristol-Myers Squibb included roles as Associate Director in US Medical Affairs for ImmunoScience and Orencia Scientific Communications Lead. He also served as Medical Director for Immunology & Inflammation at Regeneron Pharmaceuticals from 2014 to 2018, and as Lead Medical Director for US Medical Affairs - Neurology at Adamas Pharmaceuticals in 2021.
Clinical Trial Experience
Jonathan Fay has extensive experience in clinical trials, having designed, operated, interpreted, and disseminated data from Phase I-IV clinical and post-marketing trials. He has served as a medical monitor, focusing on adverse event assessment and reporting. His involvement in regulatory filing processes includes label design and negotiations, both in the United States and internationally.
Leadership and Team Management
Jonathan Fay has significant leadership experience in the pharmaceutical industry. He has led high-performing teams and evaluated life-cycle management opportunities for various products. His diverse drug experience encompasses small molecules, large fusion proteins, and antibody therapies, showcasing his ability to manage complex medical affairs and contribute to strategic decision-making.